Literature DB >> 17691773

Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist.

Youyong Li1, Fangqiang Zhu, Nagarajan Vaidehi, William A Goddard, Felix Sheinerman, Stephan Reiling, Isabelle Morize, Lan Mu, Keith Harris, Ali Ardati, Abdelazize Laoui.   

Abstract

Prostanoids play important physiological roles in the cardiovascular and immune systems and in pain sensation in peripheral systems through their interactions with eight G-protein coupled receptors. These receptors are important drug targets, but development of subtype specific agonists and antagonists has been hampered by the lack of 3D structures for these receptors. We report here the 3D structure for the human DP G-protein coupled receptor (GPCR) predicted by the MembStruk computational method. To validate this structure, we use the HierDock computational method to predict the binding mode for the endogenous agonist (PGD2) to DP. Based on our structure, we predicted the binding of different antagonists and optimized them. We find that PGD2 binds vertically to DP in the TM1237 region with the alpha chain toward the extracellular (EC) region and the omega chain toward the middle of the membrane. This structure explains the selectivity of the DP receptor and the residues involved in the predicted binding site correlate very well with available mutation experiments on DP, IP, TP, FP, and EP subtypes. We report molecular dynamics of DP in explicit lipid and water and find that the binding of the PGD2 agonist leads to correlated rotations of helices of TM3 and TM7, whereas binding of antagonist leads to no such rotations. Thus, these motions may be related to the mechanism of activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691773      PMCID: PMC2535578          DOI: 10.1021/ja070865d

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  47 in total

Review 1.  Prostanoid receptors: subtypes and signaling.

Authors:  R M Breyer; C K Bagdassarian; S A Myers; M D Breyer
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

2.  Amino acid residues conferring ligand binding properties of prostaglandin I and prostaglandin D receptors. Identification by site-directed mutagenesis.

Authors:  T Kobayashi; F Ushikubi; S Narumiya
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

3.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

4.  Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation.

Authors:  Olaf Fritze; Sławomir Filipek; Vladimir Kuksa; Krzysztof Palczewski; Klaus Peter Hofmann; Oliver P Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

5.  Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor.

Authors:  M D Ungrin; M C Carrière; D Denis; S Lamontagne; N Sawyer; R Stocco; N Tremblay; K M Metters; M Abramovitz
Journal:  Mol Pharmacol       Date:  2001-06       Impact factor: 4.436

6.  The unique ligand-binding pocket for the human prostacyclin receptor. Site-directed mutagenesis and molecular modeling.

Authors:  Jeremiah Stitham; Aleksandar Stojanovic; Bethany L Merenick; Kimberley A O'Hara; John Hwa
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

7.  Interaction of E. coli outer-membrane protein A with sugars on the receptors of the brain microvascular endothelial cells.

Authors:  Deepshikha Datta; Nagarajan Vaidehi; Wely B Floriano; Kwang S Kim; Nemani V Prasadarao; William A Goddard
Journal:  Proteins       Date:  2003-02-01

8.  Prostaglandin D2 as a mediator of allergic asthma.

Authors:  T Matsuoka; M Hirata; H Tanaka; Y Takahashi; T Murata; K Kabashima; Y Sugimoto; T Kobayashi; F Ushikubi; Y Aze; N Eguchi; Y Urade; N Yoshida; K Kimura; A Mizoguchi; Y Honda; H Nagai; S Narumiya
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

Review 9.  Cyclooxygenase 2: a molecular target for cancer prevention and treatment.

Authors:  Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Trends Pharmacol Sci       Date:  2003-02       Impact factor: 14.819

10.  Identification of residues important for ligand binding of thromboxane A2 receptor in the second extracellular loop using the NMR experiment-guided mutagenesis approach.

Authors:  Shui-Ping So; Jiaxin Wu; Gangxiong Huang; Aimin Huang; Dawei Li; Ke-He Ruan
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

View more
  16 in total

1.  Selectivity and activation of dopamine D3R from molecular dynamics.

Authors:  Zhiwei Feng; Tingjun Hou; Youyong Li
Journal:  J Mol Model       Date:  2012-07-03       Impact factor: 1.810

2.  Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1.

Authors:  Supriyo Bhattacharya; Govindan Subramanian; Spencer Hall; Jianping Lin; Abdelazize Laoui; Nagarajan Vaidehi
Journal:  J Comput Aided Mol Des       Date:  2010-05-29       Impact factor: 3.686

3.  Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptor.

Authors:  Santiago Vilar; Joel Karpiak; Stefano Costanzi
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

4.  Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor.

Authors:  Soo-Kyung Kim; Lindsay Riley; Ravinder Abrol; Kenneth A Jacobson; William A Goddard
Journal:  Proteins       Date:  2011-04-12

5.  Prediction of the three-dimensional structure for the rat urotensin II receptor, and comparison of the antagonist binding sites and binding selectivity between human and rat receptors from atomistic simulations.

Authors:  Soo-Kyung Kim; Youyong Li; Changmoon Park; Ravinder Abrol; William A Goddard
Journal:  ChemMedChem       Date:  2010-09-03       Impact factor: 3.466

6.  Structure-based prediction of subtype selectivity of histamine H3 receptor selective antagonists in clinical trials.

Authors:  Soo-Kyung Kim; Peter Fristrup; Ravinder Abrol; William A Goddard
Journal:  J Chem Inf Model       Date:  2011-11-16       Impact factor: 4.956

7.  Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor.

Authors:  Andrea Kirkpatrick; Jiyoung Heo; Ravinder Abrol; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

8.  Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins.

Authors:  Ravinder Abrol; Soo-Kyung Kim; Jenelle K Bray; Adam R Griffith; William A Goddard
Journal:  Methods       Date:  2011-12-17       Impact factor: 3.608

Review 9.  Coarse grained molecular dynamics simulations of transmembrane protein-lipid systems.

Authors:  Peter Spijker; Bram van Hoof; Michel Debertrand; Albert J Markvoort; Nagarajan Vaidehi; Peter A J Hilbers
Journal:  Int J Mol Sci       Date:  2010-06-09       Impact factor: 5.923

10.  Gauging the flexibility of the active site in soybean lipoxygenase-1 (SLO-1) through an atom-centered density matrix propagation (ADMP) treatment that facilitates the sampling of rare events.

Authors:  Prasad Phatak; Isaiah Sumner; Srinivasan S Iyengar
Journal:  J Phys Chem B       Date:  2012-08-17       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.